tc-99m depreotide

Trade name: NeoTect

PeptidewithdrawnImaging agent

Approved

Aug 3, 1999

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1990s

  1. Aug 3, 1999

    CIS Bio International S.A. — Earliest FDA Approval

  2. Aug 3, 1999

    CIS Bio International S.A. — NDA Secondary Org

  3. Aug 3, 1999

    CIS Bio International S.A. — NDA Organization

Indications

Mechanism of action

  • Unspecified targetOTHER

    Diagnostic agent

  • UnclearUnclear

    Unclear unclear

Approval history

  • withdrawnPriority reviewAug 3, 1999

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Discontinued
Imaging
99-Technetium

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • neotec
  • neo tect kit
  • neo tect kit
  • neotect kit
  • tc-99m depreotide
  • tc-99m depreotide
  • tc-99m depreotide
  • technetium (99mtc) depreotide
  • technetium tc 99m depreotide
  • technetium tc 99m depreotide
  • technetium tc 99m depreotide
  • technetium tc-99m depreotide
  • technetium tc-99m depreotide
  • technetium tc-99m depreotide

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
CIS Bio International S.A.For profitNDA2Aug 3, 1999
CIS Bio International S.A.For profitNDAAug 3, 1999